German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Introduction The Institute for Quality and Efficiency in Health Care (IQWiG), in its pursuit of promoting evidence-based healthcare decisions, continuously refines its
In this post, I’m following up on the key points on the real-world evidence (RWE) data collection in Germany with an IQWiG
Welcome to the last post in the HTA series, focusing on the changes to HTA and early benefit assessments in Germany in
This week, we are having a brief look at two brief reports on PROs recently published by the IQWiG. We’ll cover: As
Welcome, this week’s post on the G-BA’s views on endpoints is the second article in the benefit assessments series. You’ll learn about: